BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27941541)

  • 41. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
    Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Follicular lesion of undetermined significance in thyroid FNA revisited.
    Walts AE; Mirocha J; Bose S
    Diagn Cytopathol; 2014 Jan; 42(1):18-22. PubMed ID: 23894017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of ultrasound findings in the management of thyroid nodules with atypia or follicular lesions of undetermined significance.
    Yoo WS; Choi HS; Cho SW; Moon JH; Kim KW; Park HJ; Park SY; Choi SI; Choi SH; Lim S; Yi KH; Park DJ; Jang HC; Park YJ
    Clin Endocrinol (Oxf); 2014 May; 80(5):735-42. PubMed ID: 24117478
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignancy risk assessment in adenomatoid nodules and suspicious follicular lesions of the thyroid obtained by fine needle aspiration cytology.
    Dabelić N; Matesa N; Matesa-Anić D; Kusić Z
    Coll Antropol; 2010 Jun; 34(2):349-54. PubMed ID: 20698101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histologic Outcome of Indeterminate Thyroid Nodules Classified at Low or High Risk.
    Trimboli P; Fulciniti F; Merlo E; Barizzi J; Mazzucchelli L; Giovanella L
    Endocr Pathol; 2018 Mar; 29(1):75-79. PubMed ID: 29396808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations.
    Yang J; Schnadig V; Logrono R; Wasserman PG
    Cancer; 2007 Oct; 111(5):306-15. PubMed ID: 17680588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Examining the Bethesda criteria risk stratification of thyroid nodules.
    Deniwar A; Hambleton C; Thethi T; Moroz K; Kandil E
    Pathol Res Pract; 2015 May; 211(5):345-8. PubMed ID: 25796296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fine-needle aspiration of the thyroid: correlating suspicious cytology results with histological outcomes.
    Baynes AL; Del Rio A; McLean C; Grodski S; Yeung MJ; Johnson WR; Serpell JW
    Ann Surg Oncol; 2014 May; 21(5):1653-8. PubMed ID: 24390657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
    Brauner E; Holmes BJ; Krane JF; Nishino M; Zurakowski D; Hennessey JV; Faquin WC; Parangi S
    Thyroid; 2015 Jul; 25(7):789-96. PubMed ID: 25962906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specimen adequacy and diagnostic specificity of ultrasound-guided fine needle aspirations of nonpalpable thyroid nodules.
    Kelly NP; Lim JC; DeJong S; Harmath C; Dudiak C; Wojcik EM
    Diagn Cytopathol; 2006 Mar; 34(3):188-90. PubMed ID: 16470862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting thyroid nodule malignancy at several prevalence values with a combined Bethesda-molecular test.
    Lasolle H; Riche B; Decaussin-Petrucci M; Dantony E; Lapras V; Cornu C; Lachuer J; Peix JL; Lifante JC; Capraru OM; Selmi-Ruby S; Rousset B; Borson-Chazot F; Roy P
    Transl Res; 2017 Oct; 188():58-66.e1. PubMed ID: 28797549
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A tertiary center's experience with second review of 3885 thyroid cytopathology specimens.
    Olson MT; Boonyaarunnate T; Aragon Han P; Umbricht CB; Ali SZ; Zeiger MA
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1450-7. PubMed ID: 23436916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
    Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
    Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Predictive Model for Selecting Malignant Thyroid Nodules in Patients With Nondiagnostic or Indeterminate Fine-Needle Aspiration Cytologic Findings.
    Lin K; Xiang Y; Qiao L; Liu R; Dong S; Zhang X
    J Ultrasound Med; 2015 Jul; 34(7):1245-51. PubMed ID: 26112627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.
    Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK
    Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Should "indeterminate" diagnoses be used for thyroid fine-needle aspirates of nodules smaller than 1 cm?
    Renshaw AA; Gould EW
    Arch Pathol Lab Med; 2013 Nov; 137(11):1627-9. PubMed ID: 24168500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. VE1 antibody is not highly specific for the BRAF V600E mutation in thyroid cytology categories with the exception of malignant cases.
    Lee SR; Yim H; Han JH; Lee KB; Lee J; Soh EY; Kim DJ; Chung YS; Jeong SY; Sheen SS; Park SH; Kim JH
    Am J Clin Pathol; 2015 Mar; 143(3):437-44. PubMed ID: 25696803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules.
    Ferraz C; Eszlinger M; Paschke R
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2016-26. PubMed ID: 21593119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Management for thyroid nodules].
    Nakamura H
    Nihon Rinsho; 2012 Nov; 70(11):1872-9. PubMed ID: 23214055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
    Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
    Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.